Top of page
Join the ECU Social circle

Help us improve our website content by rating this page.

Page rating system

Please tell us why your content rating for this page is low.
If you'd rather not, just click Submit.

Main Content

Conference presentations

Researchers at the Centre of Excellence for Alzheimer's Disease Research and Care regularly share findings from their research at national and international conferences. Our researchers have presented the following papers in the past five years.

2009

  • The AIBL Study: Baseline data from a multicentre, prospective longitudinal study of ageing in 1100 volunteers. Ames D, Rowe C, Masters C, Martins R, Szoeke C, Hudson P, Milner A, Ellis K. 14th International Psychogeriatric Association International Congress 1-5 September 2009 Montreal Canada. Vol 21 Supp 2 S59-S60.
  • Establishment of the plasma biomarkers for the pre-symptomatic detection of AD: Australia Imaging, Biomarker and Lifestyle (AIBL) Flagship Study of Ageing. Martins RN, Gupta V, Lui J, Foster J, Taddei K, Taddei T, Brown B, Ward V, Rodrigues M, .Masters C.14th International Psychogeriatric Association International Congress 1-5 September 2009 Montreal Canada. Vol 21 Supp 2 S59-S60.
  • Amyloid-β and its relevance to the detection of Alzheimer’s disease in blood plasma: Findings from the first phase of the Australian Imaging, Biomarker and Lifestyle (AIBL) Flagship study of ageing. De Ruyck, K, Gupta V, Qiao-Xin Li, Taddei K, Foster J. Taddei T, Brown B, Ward C, Rodrigues M, Ellis K, Rowe C, Villemagne V, Hudson P, Masters C, Martins, RN, Ames D. ICAD Vienna Austria July 11-16 2009.
  • Effect of cortical placement of luteinizing Hormone on Aβ metabolism in guinea pigs. Wijaya LK, Wahjoepramono EJ, Taddei K, Martins G, Howard M, Bates KA, Dhaliwal SS, Verdile G, Martins RN, ICAD Vienna Austria July 11-16 2009. 
  • The association between APOE Levels and Alzheimer’s Disease: Australian Imaging, Biomarker and Lifestyle (AIBL) Flagship Study of Ageing. Martins RN et al. ICAD Vienna Austria July 11-16 2009.
  • Vidovich M., Almeida O., 13th Alzheimer’s Australia National Conference (Adelaide) June 2009
  • Establishment of the plasma biomarkers for the pre-symptomatic detection of AD: Australia Imaging, Biomarker and Lifestyle (AIBL) Flagship Study of Ageing. Martins RN, Gupta V, Lui J, Foster J, Taddei K, Taddei T, Brown B, Ward V, Rodrigues M, .Masters C. 24th Conference of Alzheimer’s Disease International Singapore 25-28 March 2009.
  • The Role of Physical Activity on Blood Bio-Markers Related to Alzheimers Disease Brown BM, Peiffer JJ, Taddei K, Lui J, Taddei T, Ward VK, Rodrigues MA, Rimajova M, Foster JK, Ellis K, Masters C, Ames D, Hudson P, Rowe C, Martins RN 9th International AD/PD Conference Prague March 2009
  • The role of lean body mass on cognition and blood biomarkers in a healthy control population: a component of the Australian Imaging, Biomarkers and Lifestyle (AIBL) flagship study Peiffer JJ, Brown BM, Taddei K, Lui J, Taddei T, Ward VK, Rodrigues MA, Rimajova M, Foster JK, Ellis K, Masters C, Ames D, Hudson P, Rowe C, Martins RN. 9th International AD/PD Conference Prague March 2009
  • The AIBL Study: Baseline data from a multicentre, prospective longitudinal study of ageing in 1100 volunteers. Ellis K, Rowe C, Masters C, Martins RN, Hudson P, Milner A, Bevege L, Ames D. 9th International AD/PD Conference Prague March 2009
  • Zilkens RR. Alzheimer's disease and dementia in Western Australia: Population based estimates of utilisation of health care services and outcome Alzheimer's Australia WA. Wembley, Western Australia., March 2009. (Invited Presentation)
  • DG Bruce, WA Davis, GP Casey, RM Clarnette, SG Brown, IG Jacobs, OP Almeida, TM Davis. Cognitive impairment and hypoglycaemia in older patients with diabetes: Cause or effect? VAS-Cog Conference. Platform presentation. Singapore January 2009

2008

  • Peiffer J.J., Galvao D., Turner D., Almeida O., Martins R., and Newton R.U. Go to a clinic or stay at home? Examining a 6-month home- and clinic-based resistance training program in healthy older adults. 2008 Vario Health Conference: Physical and Mental Wellness Integrated Approaches to Health. Perth, Western Australia 1st and 2nd December, 2008. 
  • Vidovich M., Almeida O.,7th National Conference of Emerging Researchers Australia (Fremantle) November 2008. 
  • Ellis KA, Rowe C, Masters CL Martins RN, Hudson P, Milner A, Bevege L, Ames D.(2008) Baseline Data from the Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing. DCRC Sept 2008 Sydney.
  • Bates KA, Sohrabi H, Rodrigues M, De Ruyck K, Beilby J, Dhaliwal SS, Criddle A, Wraith M, Howard M, Martins G, Paton A, Mehta P, Foster JK, Martins IJ, Lautenschlager N, Mastaglia FL, Laws SM, Gandy SE, Martins RN, Relationship between cardiovascular disease risk factors and Alzheimer’s disease ABeta protein in subjective memory complainers. ICAD July/August 2008.
  • Sohrabi H, Bates KA, Rodrigues M, Taddei K, Laws S, Lautenschlager N, Dhaliwal S, Johnston A, MacKay-Sim A, Foster JK, Martins RN. Frequency of forgetting is associated with olfactory functions in healthy, community-dwelling elderly. ICAD July/August 2008.
  • Martins RN, Sharman M, Taddei K, Martins I, Hone E, Berger T. Isoform-specific effects of Apoe on beta-amyloid clearance of beta and lipid metabolism. ICAD (Poster & Oral presentation) July/August 2008.
  • Ellis KA, Rowe, C, Masters CL, Martins RN, Hudson P, Milner A, Bevege L, Savage G, Ames, D. Baseline data from a multicentre, prospective longitudinal study of ageing in 100 volunteers (The AIBL Study). ICAD July/August 2008.
  • DG Bruce, WA Davis, GP Casey, SE Starkstein, OP Almeida, TM Davis. Cognitive decline in diabetes: Impact of microalbuminuria and renin-angiotensin system inhibitors. Int Conf Alzheimer’s Disease Chicago July 2008.
  • Barron, A.M., Taddei, K., Verdile, G. & Martins, R.N. (2008). Human chorionic gonadotropin elevates beta amyloid levels in a mouse model of Alzheimers disease. The Endocrine Society’s 90th Annual Meeting. 13-18 June, 2008 San Francisco, California, USA.
  • Gibbs Z., R.U. Newton, D.A. Galvão, D. Turner and K. Smith. Resistance training in older adults: A comparison between group-and home-based exercise training for improvements in functional performance, muscle function, and balance. Proceedings of the 3rd Australian Association for Exercise and Sports Science Conference and the 5th Sports Dieticians Australia Update: From Research to Practice. Page 130. Melbourne Australia 27th – 30th March 2008.
  • Anna Barron, K.Taddei, K.Croft, T.Mori, G.Verdile and R.Martins; Time and dose dependent effects of ovariectomy and human chorionic gonadotropin treatment on beta amyloid and F2-isoprostane levels in the PS1M146V knock-in mouse model of Alzheimer’s disease. Conference abstract: International Conference on Alzheimer's Disease 2008, Chicago USA.
  • Alzheimer’s Association International Conference on Alzheimer’s Disease 2008, Chicago, USA. Title of paper: “The Australian biomarker, imaging and lifestyle (ABIL) study: Preliminary PIB results” Ellis KA, Villemagne VL, Ames D, Lenzo N, Pike KE, O'Keefe G, Tochon-Danguy H, Price R, Jones G, Rimajova M, Bourgeat P, Raniga P, Fripp J, Salvado O, Martins R, Masters CL, Rowe CC.

2007

  • Poster Presentation: International Brain Research Organisation (IBRO), world congress of Neuroscience, 2007, Melbourne, Australia. Giuseppe Verdile, Roger Clarnette, Satvinder Dhaliwal, Karl De Ruyck Mark Rodrigues, Melanie Burkhardt , Jonathan K. Foster, Bu B.Yeap, David G. Bruce, Ralph N. Martins; Luteinizing hormone is positively correlated with plasma beta amyloid levels in cognitively normal elderly men”.
  • Barron A, Taddei K, Verdile G, and Martins RN (2007). Human chorionic gonadotropin increases exploratory behaviour and impairs episodic memory in PS1M146V mice. Conference abstract: The 31st Annual Meeting of the Japan Neuroscience Society, 2007, Pacifico Yokohama.
  • Invited symposium speaker, The 24th Symposium of Western Australian Neuroscience, Perth, Australia Giuseppe Verdile, Ralph Martins; The Genetics of Alzheimer’s Disease”.
  • Toye, C., Kristjanson, L. J., Auret, K., Bruce., D., Schug, S., Young, J., & Popescu., A. (2007). Refining a pain assessment self report tool for use in residential aged care. The 40th National Conference of the Australian Association of Gerontology, Adelaide, Australia Journal on Ageing, 26 (Supp. 1), A40.
  • Toye, C. (2007). Kristjanson, L. J.,Goucke, R., & McConigley, R. The Australian Pain Society's Residential Aged Care Pain Management Strategies: Development of guidelines, a toolkit, and recommendations for implementation. Oral presentation at the Western Australian Palliative Care Conference, Fremantle, Western Australia.
  • Toye, C., Popescus, A., Drake, J., & Lester, L. (2007). Effectiveness of dementia specific carer education delivered throughout Western Australia: Early findings. Poster presentation at the Alzheimer’s Australia National Conference in Perth, WA.
  • oye, C. (July, 2007). A palliative approach for people who have dementia. Invited presentation for the Western Australian Dementia Training Study Centre.
  • Toye, C. (June, 2007). Pain management in aged care. Invited presentation at Aegis Care Seminar, Perth, Western Australia.
  • Zilkens RR, Spilsbury K, Bruce DG, Semmens JB. Record linkage of hospital and death data increased identification of dementia cases and death rate estimates. (Poster). 41st Australian Association of Gerontology National Conference. Fremantle, Western Australia., November 2008.
  • Zilkens RR, Spilsbury K, Bruce DG, Semmens JB. Hospitalization trends in the last year of life in dementia. 5th Health Services and Policy Research Conference. Auckland, New Zealand.
  • ZSNM 37th Annual Scientific Meeting, Adelaide, April 2007. Title of talk: “SPECT and PET brain imaging”.
  • International Brain Research Organisation Scientific Meeting, Melbourne, July 2007. Rimajova M, Wu J, Lenzo NP, Campbell A, Bates KA, Foster JK, Martins RN. Title of paper: Altered FDG PET in Apolipoprotein E-e4 carriers with Subjective Memory Complaint”.
  • Cambridge In vitro and In vivo Molecular Imaging Meeting, San Diego Nov 2007. Rimajova M, Wu J, Lenzo NP, Campbell A, Bates KA, Foster JK, Martins RN. Title of paper: “Altered FDG PET in Apolipoprotein E-e4 carriers with Subjective Memory Complaint”.
  • Toye, C., Kristjanson, L. J., Auret, K., Bruce., D., Schug, S., Young, J., & Popescu., A. (2007). Refining a pain assessment self report tool for use in residential aged care. The 40th National Conference of the Australian Association of Gerontology, Adelaide, Australia Journal on Ageing, 26 (Supp. 1), A40.
  • Robinson, A., Abbey, J., Barnes, L., Toye, C., & Abbey, B. (2007). Best practice for undergraduate nursing students in aged care clinical placements. The 40th National Conference of the Australian Association of Gerontology, Adelaide, Australia Journal on Ageing, 26 (Supp. 1), A33.
  • Abstract: Zilkens RR, Spilsbury K, Bruce D, Semmens. Hospitalization trends in the last year of life in dementia. 5th Health Services & Policy Research Conference, Auckland, New Zealand, December 2007.
  • Oral and Poster presentation: Rimajova M, Lenzo N.P and Martins R.N. Altered FDG-PET in Apolipoprotein E4 carriers with Subjective Memory Complaint. In Vivo Molecular Imaging Conference, San Diego, US, November 2007.
  • Androgens in Health and Disease – Fifth International Conference The Royal Society of Medicine, London. The Diagnosis and Treatment of Androgen Deficiency. March 2007. Alzheimer’s Ab is differential regulated by Testosterone and Gonadotropins. EJ Wahjoepramono, L.K. Wijaya, A Barron, K Taddei, G Martins, M Howard, K. deRuyck, K. Bates, SS Dhaliwal, G. Verdile, M Carruthers, RN Martins.
  • Expert Meeting Hormones, Cognition and Dementia. Loughborough UK. March 2007. Testosterone Lowers Ab levels in both Plasma and Cerebrospinal Fluid. EJ Wahjoepramono, L.K. Wijaya, A Barron, K Taddei, G Martins, M Howard, K. deRuyck, K. Bates, SS Dhaliwal, G. Verdile, M Carruthers, RN Martins.
  • Androgens in Health and Disease – Fifth International Conference The Royal Society of Medicine, London. The Diagnosis and Treatment of Androgen Deficiency. March 2007. Serum levels of Luteinizing hormone are positively correlated with plasma beta amyloid levels in cognitively normal elderly men. G. Verdile, Bu B.Yeap, RM. Clarnette, S Dhaliwal, MS. Burkhardt, SAP. Chubb, K. De Ruyck, M. Rodrigues, PD. Mehta, JK. Foster, D. Bruce, RN. Martins.
  • Relationship between cardiovascular disease risk factors and Alzheimer’s Aβ protein in subjective memory complainers. Bates, K.A., Sohrabi, H., Rodrigues, M., De Ruyk, K., Martins, G., Dhaliwal, S., Beilby, J. and Martins, R.N. (Australia) IBRO July 07.
  • The effect of a high-cholesterol diet on Alzheimer’s disease Beta-Amyloid protein in the guinea pig Sharman, M.J., Taddei, K., Bates, K.A., De Ruyck, K., Howard, M., Verdile, G., Mehta, P. and Martins, R.N. (Australia and USA) IBRO July 07.
  • Serum levels of luteinizing hormone are positively correlated with plasma beta amyloid levels in cognitively normal elderly men. Verdile, G., Clamette, R., Dahliwal, S., De Ruyck, K., Burkhardt, M., Yeap, B.B., Bruce, D.G. and Martins, R.N. (Australia) IBRO July 07.
  • The effect of 17β-estradiol replacement on Alzheimer’s disease related neurodegenerative changes in a sheep model of menopause Barron, A.M., Verdile, G., Cake, M. and Martins, R.N. (Australia) IBRO July 07.
  • Altered FDG-PET in apolipoprotein Eε4 carriers with subjective memory complaint. Lenzo N.P., Rimajova M., Wu J.S., Campbell A., Bates K.A., Foster J.K., and Martins R.N. (Melbourne, Australia) IBRO July 07.
  • Truncated presenilin proteins inhibit normal presenilin function Nornes, S., Newman, M., Martins, R. and Lardelli, M. (Australia) IBRO July 07.
  • Prevalence of cognitive impairment of elderly people living in care homes in Sri Lanka De Zoysa, H.G.N.D., Sanjeewanie, S.A.N., Makawita, M.A.P., De Silva, K.R.D., Foster, J.K., Kathriarachchi, S.T. and Martins, R.N. (Sri Lanka and Australia) IBRO July 07.
  • Association of BAT1-22 and TNFA -850 alleles with Alzheimer’s disease Gnjec, A., D’Costa, K.J., Laws, S.M., Broe, G.A., Price, P., Hallmayer, J., McGeer, P. and Martins, R.N. (Australia, Canada) IBRO July 07.
  • Testosterone lowers beta amyloid levels in both plasma and cerebrospinal fluid. Martins RN, Wahjoepramono EJ, Wijaya LK, Taddei K, Martins G, Howard, M, De Ruyck K, Bates KA, Dhaliwal SS. Verdile G, Carruthers M. Alzheimer’s Conference in Washington USA 2007.
  • Improving cardio vascular health results in lower levels of the Alzheimer’s beta-amyloid protein. Bates KA, Rodrigues M, Sohrabi H, Martins, G, Paton A, Taddei K, Criddle A, Wraith M, Mehta P, Bilby J, Dhaliwal, Foster J, Gandy S, and Martins RN, 2007 Alzheimer’s Australia Conference.
  • The potential of quantitative MRI relaxometry for assessing and monitoring brain iron changes associated with Alzheimer’s disease. House MJ, Foster JK, St Pierre TG, Martins RN, and Clarnette R. 2007 Alzheimer’s Australia Conference.
  • Novel Phage peptides as selective inhibitors of human beta amyloid toxicity: in vitro and in vivo studies. Martins RN, Taddei K, Laws, SM, D’Costa K., Hill F., Bates K., Howard M., Sharman M, Martins IJ, Shaw J, Harvey AR. Alzheimer’s Association Prevention of Dementia Washington USA & IBRO Melbourne 2007.
  • Genetic factors in androgen deficiency and Alzheimer’s disease. Martins RN. Fifth International Conference, The diagnosis and Treatment of Androgen Deficiency – The Royal Society of Medicine, London.
  • ApoE isoforms and levels modulate beta-amyloid metabolism in vitro and in vivo. 2007 Martins RN, Sharman MJ, Taddei K., Urosevic N, Martins IJ, & Maddahi M.
  • Research opportunities in Alzheimer’s disease. Martins RN 2007. Alzheimer’s and Related Disorders Association of Kerala, India.
  • Role of gonadotropins in cell culture and the role of testosterone metabolism related genetics. Martins RN 2007. Expert Meeting: Hormones, Cognitive Function & Dementia - United Kingdom.
  • Therapeutic approaches to Alzheimer’s disease. 2007 National Institute of Mental Health and Neurosciences – Bangalore, India. Martins RN.
  • Barron A, Taddei K, Verdile G, and Martins RN (2007). Human chorionic gonadotropin increases exploratory behaviour and impairs episodic memory in PS1M146V mice. Neuroscience Research 58: Supplement 1, S62

2006

  • 36th ANZSNM Annual Scientific Meeting, Perth, Australia, May 2006. Lenzo NP. Title of papers:“Subjective memory complaint accompanies cerebral glucose metabolic changes in Apolipoprotein E-e4 gene carriers: Preliminary results” “HMPAO SPECT, FDG PET and anatomical imaging in patients with Primary Progressive Aphasia”
  • Annual Mid-Year Meeting of the International Neuropsychological Society, Zurich, Switzerland, July 2006. Title of paper: “Subjective memory complaint accompanies cerebral glucose metabolic changes in Apolipoprotein E-e4 gene carriers”
Skip to top of page